Hallett TB

Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis
Phillips AN, Cambiano V, Nakagawa F, Matharu LB, Wilson D, Jani I, Apollo T, Sculpher M, Hallett TB, Kerr C, van Oosterhout JJ, Eaton JW, Estill J, Williams BG, Doi N, Cowan F, Keiser O, Ford D, Hatzold K, Barnabas RV, Ayles H, Rath GM, Nelson L, Johnson C, Baggaley R, Fakoya A, Jahn A, Revill P

Journal of the International AIDS Society

(2019)

https://doi.org/10.1002/jia2.25325
Epidemiological metrics and benchmarks for a transition in the HIV epidemic
Ghys P, Williams BG, Over M, Hallett TB, Godfrey-Faussett P

PLoS Medicine

(2018)

https://doi.org/10.1371/journal.pmed.1002678
How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa?
Toohey C, Uhler LM, Mentor SM, Hallett TB, Keebler D, Kessler J, Scott Braithwaite R, Nucifora K

AIDS

(2014)

https://doi.org/10.1097/QAD.0000000000000110
Using modeling to inform international guidelines for antiretroviral treatment
Hallett TB, Keebler D, Revill P, Menzies NA, Bórquez A, McRobie E, Eaton JW

AIDS

(2014)

https://doi.org/10.1097/QAD.0000000000000115
Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models
Walker S, Blaser N, Easterbrook P, Borquez A, Doherty M, Cambiano V, Hirnschall G, Welte A, Ciaranello A, Keiser O, Estill J, Hallett TB, Hill A, Gray R, Kessler J, Keebler D, Menzies NA, Revill P, Nucifora KA, Braithwaite S, Vizcaya LS, Phillips AN

The Lancet Global Health

(2014)

https://doi.org/10.1016/S2214-109X(13)70048-2
HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes
Delva W, Eaton JW, Meng F, Fraser C, White RG, Vickerman P, Boily MC, Hallett TB

PLoS Medicine

(2012)

https://doi.org/10.1371/journal.pmed.1001258
HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation
Delva W, Abu-Raddad LJ, Gorgens M, Wilson D, Hallett TB, Welte A

PLoS Medicine

(2012)

https://doi.org/10.1371/journal.pmed.1001239
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa
Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A, Bloom DE, Cambiano V, Fraser C, Hontelez JA, Humair S, Klein DJ, Long EF, Phillips AN, Pretorius C, Stover J, Wenger EA, Williams BG, Hallett TB

PLoS Medicine

(2012)

https://doi.org/10.1371/journal.pmed.1001245
Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods
Kim AA, Hallett TB, Stover J, Gouws E, Musinguzi J, Mureithi PK, Bunnell R, Hargrove JW, Mermin J, Kaiser RK, Barsigo A, Ghys P

PLoS One

(2011)

https://doi.org/10.1371/journal.pone.0017535
HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review
Corbett EL, Gregson S, Gonese E, Hallett TB, Taruberekera N, Lopman B, Dorrington R, Dube S, Dehne K, Mugurungi O, Hargrove JW

International Journal of Epidemiology

(2010)

https://doi.org/10.1093/ije/dyq055
Using tests for recent infection to estimate incidence: problems and prospects for HIV
Welte A, McWalter TA, Hallett TB, Laeyendecker O

Eurosurveillance

(2010)

https://doi.org/10.2807/ese.15.24.19589-en
Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward
Mastrorea TD, Kim A, Hallett TB, Rehle T, Welte A, Laeyendecker O, Oluoch T, Garcia Calleja JM

Journal of HIV/AIDS Surveillance and Epidemiology

(2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130510/